Advertisement

Hepatic Encephalopathy: Pathophysiology—Brain

  • Julien Bissonnette
  • Christopher F. Rose
Chapter

Abstract

In liver disease, a number of systemic pathogenic factors are responsible for the onset and progression of hepatic encephalopathy. A reduced capacity of the liver to clear gut-derived ammonia leads to an increase in blood ammonia and neurotoxicity. Portal-systemic shunting as well as a reduction in muscle quality and/or muscle mass loss further increase the risk of developing hyperammonemia. Systemic oxidative stress and inflammation together with hyperammonemia can trigger cognitive decline. These factors can cross the blood-brain barrier and affect the brain directly or alter the permeability and signaling across the blood-brain barrier. Long considered a reversible disorder, there is ample amount of evidence demonstrating that repeated episodes of overt HE can prompt neuronal cell injury/death leading to irreversibility. This chapter describes a patient who embarks on the continuum of HE, describing precipitating factors involved in the pathogenesis of cognitive decline.

Keywords

Ammonia Oxidative stress Inflammation Blood-brain barrier Cell death Neurotoxicity 

References

  1. 1.
    Olde Damink SWM, Deutz NEP, Dejong CHC, et al. Interorgan ammonia metabolism in liver failure. Neurochem Int. 2002;41:177–88.CrossRefPubMedGoogle Scholar
  2. 2.
    Sokollik C, Bandsma RHJ, Gana JC, et al. Congenital portosystemic shunt: characterization of a multisystem disease. J Pediatr Gastroenterol Nutr. 2013;56:675–81.  https://doi.org/10.1097/MPG.0b013e31828b3750.CrossRefPubMedGoogle Scholar
  3. 3.
    Pereira K, Carrion AF, Martin P, et al. Current diagnosis and management of post-transjugular intrahepatic portosystemic shunt refractory hepatic encephalopathy. Liver Int. 2015;35:2487–94.  https://doi.org/10.1111/liv.12956.CrossRefPubMedGoogle Scholar
  4. 4.
    He Y, Hakvoort TBM, Vermeulen JLM, et al. Glutamine synthetase deficiency in murine astrocytes results in neonatal death. Glia. 2010;58:741–54.  https://doi.org/10.1002/glia.20960.CrossRefPubMedGoogle Scholar
  5. 5.
    Chatauret N, Desjardins P, Zwingmann C, et al. Direct molecular and spectroscopic evidence for increased ammonia removal capacity of skeletal muscle in acute liver failure. J Hepatol. 2006;44:1083–8.  https://doi.org/10.1016/j.jhep.2005.11.048.CrossRefPubMedGoogle Scholar
  6. 6.
    Merli M, Giusto M, Lucidi C, et al. Muscle depletion increases the risk of overt and minimal hepatic encephalopathy: results of a prospective study. Metab Brain Dis. 2013;28:281–4.  https://doi.org/10.1007/s11011-012-9365-z.CrossRefPubMedGoogle Scholar
  7. 7.
    Montano-Loza AJ, Angulo P, Meza-Junco J, et al. Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis. J Cachexia Sarcopenia Muscle. 2016;7:126–35.  https://doi.org/10.1002/jcsm.12039.CrossRefPubMedGoogle Scholar
  8. 8.
    Nagaraja TN, Brookes N. Intracellular acidification induced by passive and active transport of ammonium ions in astrocytes. Am J Phys. 1998;274:C883–91.CrossRefGoogle Scholar
  9. 9.
    Bosoi CR, Rose CF. Identifying the direct effects of ammonia on the brain. Metab Brain Dis. 2009;24:95–102.  https://doi.org/10.1007/s11011-008-9112-7.CrossRefPubMedGoogle Scholar
  10. 10.
    Allert N, Köller H, Siebler M. Ammonia-induced depolarization of cultured rat cortical astrocytes. Brain Res. 1998;782:261–70.CrossRefPubMedGoogle Scholar
  11. 11.
    Cooper AJ, Plum F. Biochemistry and physiology of brain ammonia. Physiol Rev. 1987;67:440–519.CrossRefPubMedGoogle Scholar
  12. 12.
    Felipo V, Butterworth RF. Neurobiology of ammonia. Prog Neurobiol. 2002;67:259–79.  https://doi.org/10.1016/S0301-0082(02)00019-9.CrossRefPubMedGoogle Scholar
  13. 13.
    Sawhney R, Holland-Fischer P, Rosselli M, et al. Role of ammonia, inflammation, and cerebral oxygenation in brain dysfunction of acute-on-chronic liver failure patients. Liver Transpl. 2016;22:732–42.  https://doi.org/10.1002/lt.24443.CrossRefPubMedGoogle Scholar
  14. 14.
    Davuluri G, Allawy A, Thapaliya S, et al. Hyperammonaemia-induced skeletal muscle mitochondrial dysfunction results in cataplerosis and oxidative stress. J Physiol. 2016;594:7341–60.  https://doi.org/10.1113/JP272796.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Felipo V. Hepatic encephalopathy: effects of liver failure on brain function. Nat Rev Neurosci. 2013;14:851–8.  https://doi.org/10.1038/nrn3587.CrossRefPubMedGoogle Scholar
  16. 16.
    Butterworth RF. Neurosteroids in hepatic encephalopathy: novel insights and new therapeutic opportunities. J Steroid Biochem Mol Biol. 2016;160:94–7.  https://doi.org/10.1016/j.jsbmb.2015.11.006.CrossRefPubMedGoogle Scholar
  17. 17.
    Görg B, Morwinsky A, Keitel V, et al. Ammonia triggers exocytotic release of L-glutamate from cultured rat astrocytes. Glia. 2010a;58:691–705.  https://doi.org/10.1002/glia.20955.CrossRefPubMedGoogle Scholar
  18. 18.
    Shah NJ, Neeb H, Kircheis G, et al. Quantitative cerebral water content mapping in hepatic encephalopathy. NeuroImage. 2008;41:706–17.  https://doi.org/10.1016/j.neuroimage.2008.02.057.CrossRefPubMedGoogle Scholar
  19. 19.
    Wright G, Soper R, Brooks HF, et al. Role of aquaporin-4 in the development of brain oedema in liver failure. J Hepatol. 2010;53:91–7.  https://doi.org/10.1016/j.jhep.2010.02.020.CrossRefPubMedGoogle Scholar
  20. 20.
    Bosoi CR, Zwingmann C, Marin H, et al. Increased brain lactate is central to the development of brain edema in rats with chronic liver disease. J Hepatol. 2014b;60:554–60.  https://doi.org/10.1016/j.jhep.2013.10.011.CrossRefPubMedGoogle Scholar
  21. 21.
    Hadjihambi A, De Chiara F, Hosford PS, et al. Ammonia mediates cortical hemichannel dysfunction in rodent models of chronic liver disease. Hepatology. 2017;65:1306–18.  https://doi.org/10.1002/hep.29031.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Sofroniew MV. Astrocyte failure as a cause of CNS dysfunction. Mol Psychiatry. 2000;5:230–2.CrossRefPubMedGoogle Scholar
  23. 23.
    Bosoi CR, Rose CF. Brain edema in acute liver failure and chronic liver disease: similarities and differences. Neurochem Int. 2013a;62:446–57.  https://doi.org/10.1016/j.neuint.2013.01.015.CrossRefPubMedGoogle Scholar
  24. 24.
    Aldridge DR, Tranah EJ, Shawcross DL. Pathogenesis of hepatic encephalopathy: role of ammonia and systemic inflammation. J Clin Exp Hepatol. 2015;5:S7–S20.  https://doi.org/10.1016/j.jceh.2014.06.004.CrossRefPubMedGoogle Scholar
  25. 25.
    Gimenez-Garzó C, Urios A, Agustí A, et al. Is cognitive impairment in cirrhotic patients due to increased peroxynitrite and oxidative stress? Antioxid Redox Signal. 2015;22:871–7.  https://doi.org/10.1089/ars.2014.6240.CrossRefPubMedGoogle Scholar
  26. 26.
    Bosoi CR, Rose CF. Oxidative stress: a systemic factor implicated in the pathogenesis of hepatic encephalopathy. Metab Brain Dis. 2013b;28:175–8.  https://doi.org/10.1007/s11011-012-9351-5.CrossRefPubMedGoogle Scholar
  27. 27.
    Coltart I, Tranah TH, Shawcross DL. Inflammation and hepatic encephalopathy. Arch Biochem Biophys. 2013;536:189–96.  https://doi.org/10.1016/j.abb.2013.03.016.CrossRefPubMedGoogle Scholar
  28. 28.
    Chen MF, Mo LR, Lin RC, et al. Increase of resting levels of superoxide anion in the whole blood of patients with decompensated liver cirrhosis. Free Radic Biol Med. 1997;23:672–9.  https://doi.org/10.1016/S0891-5849(97)00057-9.CrossRefPubMedGoogle Scholar
  29. 29.
    de Vries HE, Blom-Roosemalen MC, van Oosten M, et al. The influence of cytokines on the integrity of the blood-brain barrier in vitro. J Neuroimmunol. 1996;64:37–43.CrossRefPubMedGoogle Scholar
  30. 30.
    Didier N, Romero IA, Créminon C, et al. Secretion of interleukin-1beta by astrocytes mediates endothelin-1 and tumour necrosis factor-alpha effects on human brain microvascular endothelial cell permeability. J Neurochem. 2003;86:246–54.CrossRefPubMedGoogle Scholar
  31. 31.
    Shawcross DL, Davies NA, Williams R, Jalan R. Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. J Hepatol. 2004;40:247–54.  https://doi.org/10.1016/j.jhep.2003.10.016.CrossRefPubMedGoogle Scholar
  32. 32.
    Odeh M, Sabo E, Srugo I, Oliven A. Relationship between tumor necrosis factor-alpha and ammonia in patients with hepatic encephalopathy due to chronic liver failure. Ann Med. 2005;37:603–12.  https://doi.org/10.1080/07853890500317414.CrossRefPubMedGoogle Scholar
  33. 33.
    Shawcross DL, Sharifi Y, Canavan JB, et al. Infection and systemic inflammation, not ammonia, are associated with Grade 3/4 hepatic encephalopathy, but not mortality in cirrhosis. J Hepatol. 2011;54:640–9.CrossRefPubMedGoogle Scholar
  34. 34.
    Montoliu C, Cauli O, Urios A, et al. 3-Nitro-tyrosine as a peripheral biomarker of minimal hepatic encephalopathy in patients with liver cirrhosis. Am J Gastroenterol. 2011;106:1629–37.  https://doi.org/10.1038/ajg.2011.123.CrossRefPubMedGoogle Scholar
  35. 35.
    Bosoi CR, Parent-Robitaille C, Anderson K, et al. AST-120 (spherical carbon adsorbent) lowers ammonia levels and attenuates brain edema in bile-duct ligated rats. Hepatology. 2011;53:1995–2002.  https://doi.org/10.1002/hep.24273.CrossRefPubMedGoogle Scholar
  36. 36.
    Bosoi CR, Yang X, Huynh J, et al. Systemic oxidative stress is implicated in the pathogenesis of brain edema in rats with chronic liver failure. Free Radic Biol Med. 2012;52:1228–35.  https://doi.org/10.1016/j.freeradbiomed.2012.01.006.CrossRefPubMedGoogle Scholar
  37. 37.
    Bosoi CR, Tremblay M, Rose CF. Induction of systemic oxidative stress leads to brain oedema in portacaval shunted rats. Liver Int. 2014a;34:1322–9.  https://doi.org/10.1111/liv.12414.CrossRefPubMedGoogle Scholar
  38. 38.
    Marini JC, Broussard SR. Hyperammonemia increases sensitivity to LPS. Mol Genet Metab. 2006;88:131–7.  https://doi.org/10.1016/j.ymgme.2005.12.013.CrossRefPubMedGoogle Scholar
  39. 39.
    Rama Rao KV, Jayakumar AR, Norenberg MD. Role of oxidative stress in the ammonia-induced mitochondrial permeability transition in cultured astrocytes. Neurochem Int. 2005;47:31–8.  https://doi.org/10.1016/j.neuint.2005.04.004.CrossRefPubMedGoogle Scholar
  40. 40.
    Görg B, Qvartskhava N, Bidmon H-J, et al. Oxidative stress markers in the brain of patients with cirrhosis and hepatic encephalopathy. Hepatology. 2010b;52:256–65.  https://doi.org/10.1002/hep.23656.CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Zemtsova I, Görg B, Keitel V, et al. Microglia activation in hepatic encephalopathy in rats and humans. Hepatology. 2011;54:204–15.  https://doi.org/10.1002/hep.24326.CrossRefPubMedGoogle Scholar
  42. 42.
    Rodrigo R, Cauli O, Gomez-Pinedo U, et al. Hyperammonemia induces neuroinflammation that contributes to cognitive impairment in rats with hepatic encephalopathy. Gastroenterology. 2010;139:675–84.  https://doi.org/10.1053/j.gastro.2010.03.040.CrossRefPubMedGoogle Scholar
  43. 43.
    Planas R, Ballesté B, Alvarez MA, et al. Natural history of decompensated hepatitis C virus-related cirrhosis. A study of 200 patients. J Hepatol. 2004;40:823–30.  https://doi.org/10.1016/j.jhep.2004.01.005.CrossRefPubMedGoogle Scholar
  44. 44.
    Dhar R, Young GB, Marotta P. Perioperative neurological complications after liver transplantation are best predicted by pre-transplant hepatic encephalopathy. Neurocrit Care. 2008;8:253–8.  https://doi.org/10.1007/s12028-007-9020-4.CrossRefPubMedGoogle Scholar
  45. 45.
    Sotil EU, Gottstein J, Ayala E, et al. Impact of preoperative overt hepatic encephalopathy on neurocognitive function after liver transplantation. Liver Transplant. 2009;15:184–92.  https://doi.org/10.1002/lt.21593.CrossRefGoogle Scholar
  46. 46.
    Campagna F, Biancardi A, Cillo U, et al. Neurocognitive-neurological complications of liver transplantation: a review. Metab Brain Dis. 2010;25:115–24.  https://doi.org/10.1007/s11011-010-9183-0.CrossRefPubMedGoogle Scholar
  47. 47.
    Garcia-Martinez R, Rovira A, Alonso J, et al. Hepatic encephalopathy is associated with posttransplant cognitive function and brain volume. Liver Transpl. 2011;17:38–46.  https://doi.org/10.1002/lt.22197.CrossRefPubMedGoogle Scholar
  48. 48.
    Tryc AB, Pflugrad H, Goldbecker A, et al. New-onset cognitive dysfunction impairs the quality of life in patients after liver transplantation. Liver Transpl. 2014;20:807–14.  https://doi.org/10.1002/lt.23887.CrossRefPubMedGoogle Scholar
  49. 49.
    Brandman D, Biggins SW, Hameed B, et al. Pretransplant severe hepatic encephalopathy, peritransplant sodium and post-liver transplantation morbidity and mortality. Liver Int. 2012;32:158–64.  https://doi.org/10.1111/j.1478-3231.2011.02618.x.CrossRefPubMedGoogle Scholar
  50. 50.
    Acharya C, Wade JB, Fagan A, et al. Overt hepatic encephalopathy impairs learning on the EncephalApp stroop which is reversible after liver transplantation. Liver Transpl. 2017;23:1396–403.  https://doi.org/10.1002/lt.24864.CrossRefPubMedGoogle Scholar
  51. 51.
    Bajaj JS, Schubert CM, Heuman DM, et al. Persistence of cognitive impairment after resolution of overt hepatic encephalopathy. Gastroenterology. 2010;138:2332–40.  https://doi.org/10.1053/j.gastro.2010.02.015.CrossRefPubMedPubMedCentralGoogle Scholar
  52. 52.
    Riggio O, Ridola L, Pasquale C, et al. Evidence of persistent cognitive impairment after resolution of overt hepatic encephalopathy. Clin Gastroenterol Hepatol. 2011;9:181–3.  https://doi.org/10.1016/j.cgh.2010.10.002.CrossRefPubMedGoogle Scholar
  53. 53.
    Nardelli S, Allampati S, Riggio O, et al. Hepatic encephalopathy is associated with persistent learning impairments despite adequate medical treatment: a multicenter, international study. Dig Dis Sci. 2017;62:794–800.  https://doi.org/10.1007/s10620-016-4425-6.CrossRefPubMedGoogle Scholar
  54. 54.
    Matsusue E, Kinoshita T, Ohama E, Ogawa T. Cerebral cortical and white matter lesions in chronic hepatic encephalopathy: MR-pathologic correlations. Am J Neuroradiol. 2005;26:347–51.PubMedGoogle Scholar
  55. 55.
    Zeneroli ML, Cioni G, Vezzelli C, et al. Prevalence of brain atrophy in liver cirrhosis patients with chronic persistent encephalopathy: evaluation by computed tomography. J Hepatol. 1987;4:283–92.CrossRefPubMedGoogle Scholar
  56. 56.
    García-Lezana T, Oria M, Romero-Giménez J, et al. Cerebellar neurodegeneration in a new rat model of episodic hepatic encephalopathy. J Cereb Blood Flow Metab. 2017;37:927–37.  https://doi.org/10.1177/0271678X16649196.CrossRefPubMedGoogle Scholar
  57. 57.
    Görg B, Karababa A, Shafigullina A, et al. Ammonia-induced senescence in cultured rat astrocytes and in human cerebral cortex in hepatic encephalopathy. Glia. 2015;63:37–50.  https://doi.org/10.1002/glia.22731.CrossRefPubMedGoogle Scholar
  58. 58.
    Senzolo M, Marco S, Ferronato C, et al. Neurologic complications after solid organ transplantation. Transpl Int. 2009;22:269–78.  https://doi.org/10.1111/j.1432-2277.2008.00780.x.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.CHUMUniversité de MontréalMontréalCanada
  2. 2.CRCHUMUniversité de MontréalMontréalCanada

Personalised recommendations